Drug Used to Treat Joint Pain Recalled Over Lead Concerns...

What’s Happening

So basically Here’s a list of impacted products.

Joint pain medication, Rheumacare Capsules, is being recalled over elevated levels of lead. Food & Drug Administration sent the company a warning about some of its products. (it feels like chaos)

Here’s a list of impacted medications.

The Details

A joint pain drug is being recalled after testing by the U. Food and Drug Administration (FDA) found out it contains elevated levels of lead .

Two lots of Rheumacare Capsules were found to contain lead levels of up to 11,100ppm, and one complaint of adverse effect was made to the parent company, Handelnine Global Limited. This amount of lead is much higher than what’s generally allowed.

Why This Matters

Lead is a toxic heavy metal that may accumulate in the body over time and cause serious, long-term health effects. If you believe you have impacted medication, the FDA says to stop using it ASAP. According to one of the company’s websites , Rheumacare Capsules claim to reduce joint pain, swelling, and stiffness, and is suggested for people suffering from issues such as osteoarthritis, rheumatoid arthritis, and gout.

Medical professionals are taking note of this development.

Key Takeaways

This same letter also mentioned the discovery of elevated levels of lead after testing was conducted on two lots of the capsules.
” If you believe you have medication impacted , consult your prescriber before stopping any medication.